ArticleBreast cancer research and treatment2021

Estrogen-regulated AGR3 activates the estrogen receptor signaling pathway to promote tamoxifen resistance in breast cancer.

Rui Jiang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.